gs3-01: "trastuzumab deruxtecan vs trastuzumab emtansine in patients with her2 metastatic..."
Published 1 year ago • 404 plays • Length 15:52Download video MP4
Download video MP3
Similar videos
-
12:47
trastuzumab deruxtecan vs trastuzumab emtansine in patients with her2 metastatic breast cancer
-
5:26
trastuzumab deruxtecan shows benefit in patients with her2 mbc
-
3:36
trastuzumab deruxtecan in patients with breast cancer and brain metastases in destiny-breast01
-
1:12
trastuzumab deruxtecan in metastatic her2 breast cancer
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
2:12
trastuzumab deruxtecan in her2-low advanced breast cancer | nejm
-
5:40
trastuzumab deruxtecan doubles pfs in metastatic breast cancer with low her2 expression
-
1:09
trastuzumab emtansine with trastuzumab, pertuzumab, and docetaxel metastatic her2 breast cancer
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
5:09
trastuzumab deruxtecan shows benefit across her2 metastatic breast cancer subgroups
-
2:06
trastuzumab deruxtecan for breast cancer | nejm
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
2:08
destiny-breast07: t-dxd /- pertuzumab in patients with metastatic her2 breast cancer
-
2:16
sabcs 2022: destiny-breast02 destiny-breast03
-
20:10
breast cancer breakthroughs episode one: highlights from the san antonio breast cancer symposium
-
7:45
trastuzumab emtansine in her2 breast cancer
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
8:42
trastuzumab deruxtecan in her2 breast cancer
-
21:00
gs4 10 neratinib fulvestrant trastuzumab for hormone receptor-positive, her2-mutant metastatic